Eli Lilly and Company
The Director of Engineering for Synthetic Molecule Design and Development leads unit operation development and process optimization for synthetic drug candidates, supporting clinical trials, regulatory submissions, and commercialization. This role involves leading cross-disciplinary teams of process chemists, analytical chemists, formulation scientists, and engineers to design and develop new synthetic routes and manufacturing technologies. The position requires deep technical expertise in chemical engineering and synthetic organic chemistry to drive innovation and ensure the successful delivery of life-changing medicines.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Process Chemistry Lead (Small Molecule)
AstraZeneca
Senior Scientist II, Process Chemistry
Exelixis
Associate Director, Chemical Development
AstraZeneca
Undergraduate Co-op – Drug Substance Technologies Synthetics - Massachusetts (July – December 2026)
Amgen
Postdoctoral Fellow/Synthetic Chemist; Chemistry Zaleski Lab
Indiana University
Associate Director, CMC Synthetic Chemistry – Small Molecule
Beeline Medicines